Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-18T21:40:02.412Z Has data issue: false hasContentIssue false

Evaluation of intravenous amoxicillin-clavulanate use in two Canadian hospitals

Published online by Cambridge University Press:  14 February 2024

Maggie Wong
Affiliation:
Department of Pharmacy, Royal Columbian Hospital, New Westminster, BC, Canada
Sangita Malhotra
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaDivision of Infectious Diseases, Department of Medicine, Fraser Health Authority, New Westminster, BC, Canada
Kevin Afra*
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaDivision of Infectious Diseases, Department of Medicine, Fraser Health Authority, Surrey, BC, Canada
*
Corresponding author: Kevin Afra; Email: kevin.afra@fraserhealth.ca

Abstract

We describe our experience with intravenous amoxicillin-clavulanate, which is new to the Canadian market. The majority of patients were successfully de-escalated from piperacillin-tazobactam or a carbapenem for respiratory infections or skin and soft tissue infections. Intravenous amoxicillin-clavulanate provides a good alternative in an era of rising Pseudomonas aeruginosa resistance.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Summary of patient demographics and prescribing pattern of intravenous (IV) amoxicillin-clavulanate

Figure 1

Table 2.Summary of primary and secondary outcomes

Supplementary material: File

Wong et al. supplementary material

Wong et al. supplementary material
Download Wong et al. supplementary material(File)
File 14 KB